Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Hepatocyte growth factor receptor | ||
Ligand | BDBM50157880 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1565901 (CHEMBL3790005) | ||
IC50 | >10000±n/a nM | ||
Citation | Fairhurst, RA; Marsilje, TH; Stutz, S; Boos, A; Niklaus, M; Chen, B; Jiang, S; Lu, W; Furet, P; McCarthy, C; Stauffer, F; Guagnano, V; Vaupel, A; Michellys, PY; Schnell, C; Jeay, S Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. Bioorg Med Chem Lett26:2057-64 (2016) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Hepatocyte growth factor receptor | |||
Name: | Hepatocyte growth factor receptor | ||
Synonyms: | Hepatocyte growth factor receptor | Hepatocyte growth factor receptor (MET) | Hepatocyte growth factor receptor (c-MET) | Hepatocyte growth factor receptor (cMET) | MET | MET_HUMAN | Met proto-oncogene (hepatocyte growth factor receptor) | Proto-oncogene c-Met | Tyrosine-protein kinase Met (c-Met) | Tyrosine-protein kinase Met (cMet) | c-Met kinase | ||
Type: | Protein | ||
Mol. Mass.: | 155559.73 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P08581 | ||
Residue: | 1390 | ||
Sequence: |
| ||
BDBM50157880 | |||
n/a | |||
Name | BDBM50157880 | ||
Synonyms: | CHEMBL3787112 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H23N5O | ||
Mol. Mass. | 349.4295 | ||
SMILES | Nc1ncnc2n(cc(-c3cccc(O)c3)c12)[C@@H]1C[C@H](CN2CCC2)C1 |r,wD:17.19,19.22,(-1.03,2.79,;-1.03,1.55,;-2.38,.77,;-2.38,-.77,;-1.03,-1.55,;.3,-.77,;1.76,-1.24,;2.66,.02,;1.76,1.24,;2.23,2.7,;3.76,2.91,;4.33,4.34,;3.38,5.56,;1.86,5.34,;1.1,6.31,;1.29,3.91,;.3,.77,;2.24,-2.7,;3.54,-3.45,;2.74,-4.76,;3.1,-6.25,;4.58,-6.69,;5.27,-8.02,;6.62,-7.28,;5.88,-5.93,;1.42,-3.96,)| | ||
Structure |